United States · Bill · S
S. 1218 (118th)
Fair Prescription Drug Prices for Americans Act
Introduced
19 April 2023
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
—
Subjects
Discovery layer
Source updated
27 May 2025
Summary
Fair Prescription Drug Prices for Americans Act This bill caps the price of drugs and biologics at the average price among certain countries. Specifically, the retail list price of a drug or biologic in the United States may not exceed the average retail list price among Canada, France, Germany, Italy, Japan, and the United Kingdom. The Department of Health and Human Services (HHS) must calculate the average price in these countries based on data that is submitted by manufacturers directly to HHS and on publicly filed materials from manufacturers. Manufacturers who violate the bill's price cap are subject to civil penalties.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 19 April 2023
Introduced in Senate (PDF)
Introduced in Senate · EN · 19 April 2023
Introduced in Senate
summary · EN · 19 April 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/senate-bill/1218
- Open data entity: https://api.congress.gov/v3/bill/118/s/1218